131 related articles for article (PubMed ID: 2130005)
21. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
Digranes A; Benonisen E; Dibb WL
Infection; 1982; 10(5):307-9. PubMed ID: 6293978
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Hoogkamp-Korstanje JA; Meijer CA
Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
[TBL] [Abstract][Full Text] [Related]
23. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
[TBL] [Abstract][Full Text] [Related]
24. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
[TBL] [Abstract][Full Text] [Related]
25. [Activity of cefotetan against anaerobic bacteria].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
[TBL] [Abstract][Full Text] [Related]
27. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
Machka K; Dietz R
Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
[TBL] [Abstract][Full Text] [Related]
28. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
[TBL] [Abstract][Full Text] [Related]
29. [Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections].
Salvo S; Falcidia A; Mirone L
Minerva Med; 1987 Jan; 78(2):71-7. PubMed ID: 3543744
[TBL] [Abstract][Full Text] [Related]
30. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
32. [The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
Bauernfeind A; Grimm H; Klietmann W; Opferkuch W; Werner H
Arzneimittelforschung; 1991 Aug; 41(8):831-8. PubMed ID: 1781806
[TBL] [Abstract][Full Text] [Related]
33. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Bakhtiar M; Selwyn S
Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
Aldridge KE; Sanders CV; Marier RL
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
[TBL] [Abstract][Full Text] [Related]
35. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
36. Newer beta-lactam agents and the Bacteroides fragilis group.
Cuchural GJ
Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
[TBL] [Abstract][Full Text] [Related]
38. [Detection of extended broad-spectrum beta-lactamases with the ATB MIC system].
Ronco E; Migueres ML; Guenounou M; Philippon A
Pathol Biol (Paris); 1991 May; 39(5):480-5. PubMed ID: 1881678
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli.
Liebowitz LD; Klugman KP
S Afr Med J; 1996 Oct; 86(10):1276-80. PubMed ID: 8955735
[TBL] [Abstract][Full Text] [Related]
40. The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):37S-46S. PubMed ID: 6086217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
